NorthX Biologics, a leading Nordic biopharmaceutical Contract, Development and Manufacturing Organization (CDMO), is pleased to announce a significant growth investment from Signet Healthcare Partners (Signet), a U.S.-based healthcare private equity firm with deep expertise in pharmaceutical services. This strategic partnership will enable NorthX Biologics to accelerate its expansion plans, including enhancing facilities, broadening service lines, and extending U.S. commercial reach. NorthX Biologics provides a wide range of complex biologics manufacturing services, including recombinant proteins, viral vaccines and cell therapies.
Read the full article: NorthX Biologics Secures Significant Growth Investment from Signet Healthcare Partners //
Source: https://www.businesswire.com/news/home/20250520072368/en/NorthX-Biologics-Secures-Significant-Growth-Investment-from-Signet-Healthcare-Partners